Clinical trials
Completed Hematologic Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
156 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 6 |
| 2001 | 3 |
| 2003 | 4 |
| 2004 | 4 |
| 2005 | 7 |
| 2006 | 4 |
| 2007 | 3 |
| 2008 | 5 |
| 2009 | 11 |
| 2010 | 9 |
| 2011 | 7 |
| 2012 | 7 |
| 2013 | 7 |
| 2014 | 5 |
| 2015 | 7 |
| 2016 | 3 |
| 2017 | 12 |
| 2018 | 9 |
| 2019 | 7 |
| 2020 | 9 |
| 2021 | 4 |
| 2022 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 156 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Seagen Inc. | 23 |
| National Heart, Lung, and Blood Institute (NHLBI) | 11 |
| M.D. Anderson Cancer Center | 6 |
| BioMarin Pharmaceutical | 4 |
| Emory University | 4 |
| Medical College of Wisconsin | 4 |
| Novartis Pharmaceuticals | 4 |
| Boston Children's Hospital | 3 |
| Ellodi Pharmaceuticals, LP | 3 |
| Fairview University Medical Center | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Diseases | 156 |
| Leukemia | 23 |
| Genetic Diseases, Inborn | 22 |
| Lymphoma | 20 |
| Multiple Myeloma | 19 |
| Anemia, Sickle Cell | 18 |
| Blood Coagulation Disorders | 17 |
| Rare Diseases | 16 |
| Hemorrhagic Disorders | 15 |
| Lymphoma, Non-Hodgkin | 15 |
Trials
Showing 1 to 25 of 156. Each trial links to its page on Pharma Observatory.
56 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.